Structure Therapeutics has a strong cash position with a runway of 18-20 quarters, but the drug's potential is not fully ...

Kathy Bates hits the red carpet in style showing off her lovely slim figure after Ozempic weight loss attending the 2025 ...

There are more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.

Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...

Jimmy Carter dies at 100. 179 people were killed in South Korea in a deadliest place crash of 2024. Trump praises H-1B visas.

In this first weekly piece of the year, we will look at the "dogs" of the ASX from 2024, see how 2023 Dogs performed and mark ...

Merck & Co. snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as $2 billion.

The news caused shares of two biotechs developing weight-loss drugs, Viking Therapeutics and Structure Therapeutics ... GLP-1 is the same gut hormone mimicked by injectable drugs such as Ozempic and ...

The most recent, Ozempic and Mounjaro ... reflects a potential 173.41% increase from the current price of $6.92. Structure Therapeutics Inc. (NASDAQ:GPCR) is a clinical-stage biopharmaceutical ...

It would have been impossible to predict then that she'd become instrumental in the development of the popular class of injectable diabetes and weight loss drugs like Ozempic and Wegovy that have ...

This year saw several advancements across medicine, space technology, and AI that extend our knowledge in consequential ways.